Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 1, 1996, Pages 59-66

  Webster, C A ^a   Curran, R ^a   Towner, K J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFACLOR; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ARTICLE; COMMUNICABLE DISEASE; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; URINARY TRACT INFECTION;

AMPICILLIN; CEFACLOR; CEPHALOSPORINS; COMMUNITY-ACQUIRED INFECTIONS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; URINARY TRACT INFECTIONS;

EID: 0030179954     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.1.59     Document Type: Review

References (13)

1. Barrow, G. I. & Feltham, R. K. A. (1993). Characters of Gram-negative bacteria. In Cowan and Steel's Manual for the Identification of Medical Bacteria, 3rd Edn, pp. 94-164. Cambridge University Press, Cambridge.
2. Brumfitt, W. & Hamilton-Miller, J. M. T. (1990). Prophylactic antibiotics for recurrent urinary tract infections. Journal of Antimicrobial Chemotherapy 25, 505-12.
3. Brumfitt, W. & Hamilton-Miller, J. M. T. (1995). A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 23, 98-102.
4. Carter, G. I., Towner, K. J., Pearson, N. J. & Slack, R. C. B. (1989). Use of a non-radioactive hybridization assay for direct detection of gram-negative bacteria carrying TEM β-lactamase genes in infected urine. Journal of Medical Microbiology 28, 113-7.
5. Eley, A., Ambler, J. & Greenwood, D. (1983). Isoelectric focusing of beta-lactamases on cellulose acetate membranes. Journal of Antimicrobial Chemotherapy 12, 193-6.
6. Geha, D. J., Uhl, J. R., Gustaferro, C. A. & Persing, D. H. (1994). Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory. Journal of Clinical Microbiology 32, 1768-72.
7. Hamilton-Miller, J. M. T., Iravani, A., Brumfitt, W., Byers, K. S. & Dere, W. H. (1992). Comparative trials of cefaclor AF in uncomplicated cystitis and asymptomatic bacteriuria. Postgraduate Medical Journal 68, Suppl. 3, S60-7.
8. Moellering, R. C. & Waldvogel, F. A. eds (1988). Cefaclor: a decade of experience. Clinical Therapeutics 11, Suppl. A, 1-74.
9. Pearson, N. J., Towner, K. J., McSherry, A. M., Cattell, W. R. & O'Grady, F. (1979). Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection. Lancet ii, 1205-9.
10. Preston, D. A. (1993). Global surveillance of bacterial susceptibility to cefaclor: 1988-1990. Clinical Therapeutics 15, 88-96.
11. Tenover, F. C., Huang, M. B., Rasheed, J. K. & Parsing, D. H. (1994). Development of PCR assays to detect ampicillin resistance genes in cerebrospinal fluid samples containing Haemophilus influenzae. Journal of Clinical Microbiology 32, 2729-37.
12. Thornsberry, C. (1992). Cefaclor AF: correlation of microbiology and clinical outcome. Postgraduate Medical Journal 68, Suppl. 3, S10-6.
13. Towner, K. J. (1992). Resistance to antifolate antibacterial agents. Journal of Medical Microbiology 36, 4-6.